1.A case of delayed sleep phase syndrome.
Journal of Korean Neuropsychiatric Association 1992;31(1):182-187
No abstract available.
Sleep Disorders, Circadian Rhythm*
2.Pharmacological treatment of insomnia.
Korean Journal of Medicine 2001;61(4):453-456
No abstract available.
Sleep Initiation and Maintenance Disorders*
3.Pharmacological treatment of insomnia.
Korean Journal of Medicine 2005;68(2):244-247
No abstract available.
Sleep Initiation and Maintenance Disorders*
4.Pharmacological Treatment of Sleep Disorders.
Journal of the Korean Medical Association 1999;42(1):90-97
No abstract available.
Sleep Wake Disorders*
5.Some opinions of the impact of zinc complement in the sleep disorder in children
Journal of Practical Medicine 2002;435(11):27-30
Remarks on influences of zinc deficiency to sleep in children and effects of zinc supplementation to sleep disorders in children. Exploring 104 chronic anorexic and malnourished children aged 3 -36 months were divided into two groups named A and B. Both groups have been similar age, sex, clinical symptoms and monitored, guided and treated with the same regime and scheme. A comparative study on the differences of some selected indicators between children in group A whose dietary intake was added a dose of 10 mg zinc gluconate/day/child and others in control group B have been carried out. The results show that 53% of them were low zinc deficiency, sleep duration of them were short, with 69% of them had sleep disorders and were at 3 times higher risk of getting sleep disorders compared with children without lacking zinc (p<0,01). Besides the effects were known, zinc’s supplementation has effected to treat clearly to sleep disorder in children. It may be an useful characteristic of zinc element which has been identified at the first time, so it is necessary to keep on study more.
Sleep Disorders
;
Child
6.Non-pharmacological Treatments of Chronic Insomnia.
Journal of the Korean Medical Association 2001;44(7):750-760
No abstract available.
Sleep Initiation and Maintenance Disorders*
7.New Trends of Treatments in Sleep Disorder Breathing.
Journal of the Korean Medical Association 2000;43(6):560-568
No abstract available.
Respiration*
;
Sleep Wake Disorders*
8.Management of insomnia.
Journal of the Korean Academy of Family Medicine 2001;22(8):1163-1174
No abstract available.
Sleep Initiation and Maintenance Disorders*
9.Sleep Disorder of Shift Workers
Journal of Korean Medical Science 2019;34(50):327-
No abstract available.
Sleep Wake Disorders
10.Efficacy and safety of suvorexant for the treatment of primary insomnia among Chinese: A 6-month randomized double-blind controlled study
Baiya Fan ; Jing Kang ; Yalong He ; Meimei Hao ; Wei Du ; Shihong Ma
Neurology Asia 2017;22(1):41-47
Background: Insomnia often responds to the orexin receptor antagonist suvorexant. This study aimed to
evaluate the efficacy and adverse events of suvorexant for Chinese patients with primary insomnia over 6
months. Methods: A total of 120 patients with primary insomnia were assigned randomly to two groups
that received placebo or suvorexant (40 mg) for 6 months. The primary outcomes were the total sleep time
(sTST), time to sleep onset (sTSO), and sleep quality (sQUAL). The secondary outcomes were the Insomnia
Severity Index (ISI) score and adverse events. Results: A total of 111 patients completed the study and
all of them were included in the final analysis. Suvorexant showed greater efficacy than the placebo in
enhancing sTST, sTSO, sQUAL and ISI score at months 1 and 6. Serious adverse events were documented
in 2 patients (3.3%) in the suvorexant group and 1 patients (1.7%) in the placebo group. The most common
adverse event was somnolence, which occurred in 7 patients (11.7%) in the suvorexant group and 2 patients
(3.3%) in the placebo group. No death related to suvorexant treatment was recorded.
Conclusions: Suvorexant was efficacious and well-tolerated in a group of Chinese patients with primary
insomnia over 6 months.
Sleep Initiation and Maintenance Disorders
Result Analysis
Print
Save
E-mail